Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Return on Equity (2021 - 2025)

Coeptis Therapeutics Holdings has reported Return on Equity over the past 5 years, most recently at 1.0% for Q4 2025.

  • Quarterly results put Return on Equity at 1.0% for Q4 2025, up 160.0% from a year ago — trailing twelve months through Dec 2025 was 1.0% (up 160.0% YoY), and the annual figure for FY2025 was 1.41%, up 378.0%.
  • Return on Equity for Q4 2025 was 1.0% at Coeptis Therapeutics Holdings, up from 1.57% in the prior quarter.
  • Over the last five years, Return on Equity for COEPW hit a ceiling of 99.86% in Q1 2024 and a floor of 19.43% in Q2 2022.
  • Median Return on Equity over the past 5 years was 4.97% (2024), compared with a mean of 0.9%.
  • Biggest five-year swings in Return on Equity: surged 10980bps in 2024 and later tumbled -10194bps in 2025.
  • Coeptis Therapeutics Holdings' Return on Equity stood at 8.76% in 2021, then plummeted by -177bps to 6.71% in 2022, then plummeted by -134bps to 15.71% in 2023, then soared by 83bps to 2.6% in 2024, then surged by 61bps to 1.0% in 2025.
  • The last three reported values for Return on Equity were 1.0% (Q4 2025), 1.57% (Q3 2025), and 1.73% (Q2 2025) per Business Quant data.